{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:40:27Z","timestamp":1782052827552,"version":"3.54.5"},"reference-count":44,"publisher":"CSIRO Publishing","issue":"6","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":654,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["14549"],"award-info":[{"award-number":["14549"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>HIV pre-exposure prophylaxis (PrEP) in Australia has largely been targeted at gay, bisexual and other men who have sex with men. In the context of HIV elimination, the aim of this qualitative study was to explore PrEP prescribing for Australian cisgender women from the provider\u2019s perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Semi-structured interviews were held with Australian prescribers in 2022. Participants were recruited through relevant clinical services, newsletter distribution and snowball sampling. Interviews were audio-recorded, transcribed and analysed thematically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventeen prescribers participated, of whom 9 were sexual health physicians and 10 worked in New South Wales. All reported limited clinical experience prescribing PrEP for women. Potential enablers to PrEP prescribing to women included education for women and clinicians, easily identifiable risk factors, individualised risk assessment and expansion of existing services. Barriers were limited PrEP awareness among women and prescribers, difficulties with risk assessment and consult and service limitations. The type of service recommended for PrEP provision varied among participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Clinician experience of PrEP prescribing to Australian cisgender women is limited, with substantial barriers to access perceived by prescribers. Targeted education to PrEP prescribers, updated national PrEP guidelines to include women as a distinct group and further research regarding women\u2019s preferred model of PrEP access are required. Clarity of clinical ownership over PrEP implementation for women and, more broadly, women\u2019s sexual health, is essential in order to achieve HIV elimination in Australia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh23163","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T18:12:32Z","timestamp":1698689552000},"page":"558-565","source":"Crossref","is-referenced-by-count":4,"title":["Provider views of pre-exposure prophylaxis (PrEP) for cisgender women \u2013 where do women fit in HIV elimination in Australia?"],"prefix":"10.1071","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1441-1177","authenticated-orcid":true,"given":"Caroline","family":"Lade","sequence":"first","affiliation":[{"name":"AIllawarra Shoalhaven Local Health District, Illawarra Shoalhaven Sexual Health Service, Port Kembla Hospital, Cowper Street, Warrawong, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0614-0157","authenticated-orcid":true,"given":"Catherine","family":"MacPhail","sequence":"additional","affiliation":[{"name":"BUniversity of Wollongong, School of Health and Society, Building 29, Northfields Avenue, Wollongong, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6838-0498","authenticated-orcid":true,"given":"Alison","family":"Rutherford","sequence":"additional","affiliation":[{"name":"AIllawarra Shoalhaven Local Health District, Illawarra Shoalhaven Sexual Health Service, Port Kembla Hospital, Cowper Street, Warrawong, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"2025102615400121700_R1"},{"key":"2025102615400121700_R2"},{"key":"2025102615400121700_R3"},{"key":"2025102615400121700_R4"},{"key":"2025102615400121700_R5"},{"key":"2025102615400121700_R6"},{"key":"2025102615400121700_R7","unstructured":"Power J, Amir S, Brown G, Rule J, Johnson J, Lyons A, et al. HIV Futures 9. Melbourne: La Trobe University; 2019. Report No.: 116."},{"key":"2025102615400121700_R8"},{"key":"2025102615400121700_R9"},{"key":"2025102615400121700_R10"},{"key":"2025102615400121700_R11","unstructured":"Centers for Disease Control and Prevention. HIV surveillance supplemental report. Centers for Disease Control and Prevention; 2021. Available at https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance\/vol-26-no-2\/index.html [cited 19 November 2022]"},{"issue":"1","key":"2025102615400121700_R12","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26056","article-title":"Discontinuation of government subsidised HIV pre-exposure prophylaxis in Australia: a whole-of-population analysis of dispensing records.","volume":"26","author":"Medland","year":"2023","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"2025102615400121700_R13","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1080\/09540121.2017.1286287","article-title":"Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic.","volume":"29","author":"Blackstock","year":"2017","journal-title":"AIDS Care"},{"issue":"1","key":"2025102615400121700_R14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/nur.20362","article-title":"What\u2019s in a name? Qualitative description revisited.","volume":"33","author":"Sandelowski","year":"2010","journal-title":"Res Nurs Health"},{"issue":"1","key":"2025102615400121700_R15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/nur.21768","article-title":"Characteristics of qualitative descriptive studies: a systematic review.","volume":"40","author":"Kim","year":"2017","journal-title":"Res Nurs Health"},{"key":"2025102615400121700_R16"},{"issue":"7227","key":"2025102615400121700_R17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/bmj.320.7227.114","article-title":"Qualitative research in health care. Analysing qualitative data.","volume":"320","author":"Pope","year":"2000","journal-title":"BMJ"},{"issue":"4","key":"2025102615400121700_R18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/15248399221086616","article-title":"Preexposure prophylaxis implementation in a reproductive health setting: perspectives from planned parenthood providers and leaders.","volume":"24","author":"Wilbourn","year":"2023","journal-title":"Health Promot Pract"},{"issue":"9","key":"2025102615400121700_R19","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1089\/jwh.2018.7353","article-title":"Factors affecting pre-exposure prophylaxis implementation for women in the United States: a systematic review.","volume":"28","author":"Bradley","year":"2019","journal-title":"J Womens Health"},{"issue":"S1","key":"2025102615400121700_R20","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1097\/QAI.0000000000002974","article-title":"Provider perspectives on factors affecting the PrEP care continuum among black cisgender women in the midwest United States: applying the consolidated framework for implementation research.","volume":"90","author":"Johnson","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025102615400121700_R21","unstructured":"QSR International Pty Ltd. NVivo (Version 12) 2020. Available at https:\/\/www.qsrinternational.com\/nvivo-qualitative-data-analysis-software\/home"},{"key":"2025102615400121700_R22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research.","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"2025102615400121700_R23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"2025102615400121700_R24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"2025102615400121700_R25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10508-020-01903-8","article-title":"Pre-exposure prophylaxis (PrEP) for HIV infection in cisgender and transgender women in the U.S.: a narrative review of the literature.","volume":"50","author":"Baldwin","year":"2021","journal-title":"Arch Sex Behav"},{"issue":"4","key":"2025102615400121700_R26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/QAI.0000000000002042","article-title":"Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP.","volume":"81","author":"Calabrese","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"2025102615400121700_R27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/sextrans-2020-054457","article-title":"Risk perception, safer sex practices and PrEP enthusiasm: barriers and facilitators to oral HIV pre-exposure prophylaxis in Black African and Black Caribbean women in the UK.","volume":"96","author":"Nakasone","year":"2020","journal-title":"Sex Transm Infect"},{"issue":"1","key":"2025102615400121700_R28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/QAI.0000000000001879","article-title":"Brief report: pre-exposure prophylaxis awareness and use among cisgender women at a sexually transmitted disease clinic.","volume":"80","author":"Raifman","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"2025102615400121700_R29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000001950","article-title":"Brief report: PrEP eligibility among at-risk women in the southern United States: associated factors, awareness, and acceptability.","volume":"80","author":"Patel","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2025102615400121700_R30","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-021-01348-8","article-title":"\u201cPrEP\u201ding for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women.","volume":"21","author":"Pasipanodya","year":"2021","journal-title":"BMC Womens Health"},{"issue":"5","key":"2025102615400121700_R31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/QAI.0000000000002377","article-title":"Black cisgender women\u2019s PrEP knowledge, attitudes, preferences, and experience in Chicago.","volume":"84","author":"Hirschhorn","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2025102615400121700_R32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/apc.2014.0142","article-title":"Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.","volume":"29","author":"Auerbach","year":"2015","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"2025102615400121700_R33","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s10461-016-1625-1","article-title":"PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists.","volume":"21","author":"Petroll","year":"2017","journal-title":"AIDS Behav"},{"issue":"3","key":"2025102615400121700_R34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.22454\/FamMed.2022.698419","article-title":"Assessing HIV preexposure prophylaxis education in a family medicine residency.","volume":"54","author":"Aurora","year":"2022","journal-title":"Fam Med"},{"issue":"1","key":"2025102615400121700_R35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/14461242.2019.1703781","article-title":"Troubling the non-specialist prescription of HIV pre-exposure prophylaxis (PrEP): the views of Australian HIV experts.","volume":"29","author":"Smith","year":"2020","journal-title":"Health Sociol Rev"},{"key":"2025102615400121700_R36"},{"issue":"9","key":"2025102615400121700_R37","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000730","article-title":"Stigma, partners, providers and costs: potential barriers to PrEP uptake among US women.","volume":"8","author":"Goparaju","year":"2017","journal-title":"J AIDS Clin Res"},{"issue":"9","key":"2025102615400121700_R38","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1007\/s10461-014-0839-3","article-title":"HIV providers\u2019 perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.","volume":"18","author":"Krakower","year":"2014","journal-title":"AIDS Behav"},{"issue":"1","key":"2025102615400121700_R39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/2325957415600798","article-title":"A clinical home for preexposure prophylaxis: diverse health care providers\u2019 perspectives on the \u201cPurview Paradox\u201d.","volume":"15","author":"Hoffman","year":"2016","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"5","key":"2025102615400121700_R40","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/cid\/cit796","article-title":"Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada.","volume":"58","author":"Karris","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2025102615400121700_R41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1071\/SH20208","article-title":"Challenges of providing HIV pre-exposure prophylaxis across Australian clinics: qualitative insights of clinicians.","volume":"18","author":"Smith","year":"2021","journal-title":"Sex Health"},{"issue":"5","key":"2025102615400121700_R42","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10461-016-1663-8","article-title":"Reaching key populations: PrEP uptake in an urban health care system in the Bronx, New York.","volume":"21","author":"Bien","year":"2017","journal-title":"AIDS Behav"},{"key":"2025102615400121700_R43"},{"key":"2025102615400121700_R44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tmaid.2018.12.006","article-title":"Sexual safety and HIV prevention in travel medicine: practical considerations and new approaches.","volume":"28","author":"Cornelisse","year":"2019","journal-title":"Travel Med Infect Dis"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/20\/6\/558\/693282\/sh23163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/20\/6\/558\/693282\/sh23163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:40:06Z","timestamp":1761507606000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/20\/6\/558\/86585\/Provider-views-of-pre-exposure-prophylaxis-PrEP"}},"subtitle":[],"editor":[{"given":"Anthony","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12,12]]}},"URL":"https:\/\/doi.org\/10.1071\/sh23163","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}